Ulcerative colitis trials in South Korea

In South Korea 24 Also abroad 382

24 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 2Enrolling by invitation
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
Where
Busan, Daegu, Daejeon, Seoul, Wŏnju
Age
18 years and over
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07652294 · EU 2025-524640-35-00
Phase 2Taking people
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Where
Busan, Daegu, Daejeon, Gwangju, Gyeongsan-si, Pusan, Seoul, Wŏnju
Age
18 years to 80 years
People
1,431 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07415044
Phase 3Taking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Seoul
Age
3 years to 64 years
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
Phase 3Taking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Ansan, Busan, Daejeon, Ganggu, Seoul, Tongdaemun-Gu
Age
18 years and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00
Phase 2Taking people
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Where
Busan, Daejeon, Gwangju, Seoul, Wŏnju
Age
18 years and over
People
224 worldwide
Run by
Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00
Phase 2Taking people
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Where
Busan, Daegu, Daejeon, Seoul, Suwon, Wŏnju
Age
18 years to 75 years
People
645 worldwide
Run by
Spyre Therapeutics, Inc.
See details and how to joinNCT07012395 · EU 2025-521242-26-00
Phase 3Taking people
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Where
Seoul, Yangsan
Age
2 years to 17 years
People
120 worldwide
Run by
AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00
Phase 2Taking people
A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Where
Ansan-si, Seoul, Wŏnju
Age
18 years to 75 years
People
100 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT07463183 · EU 2025-523479-49-00
Phase 3Taking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Ansan-si, Busan, Daegu, Seoul, Suwon
Age
16 years to 80 years
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
Phase 3Taking people
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Daegu, Seoul
Age
2 years to 17 years
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06405087 · EU 2023-508804-39-00
Phase 3Taking people
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Where
Deagu, Seoul
Age
2 years to 19 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT04844606
Phase 3Taking people
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Where
Daegu, Seoul
Age
2 years to 17 years
People
70 worldwide
Run by
Takeda
See details and how to joinNCT06100289 · EU 2023-503188-40-00
No phaseTaking people
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Where
Ansan, Bucheon-si, Busan, Changwon, Cheonan, Cheongju-si, Chuncheon, Daegu, Daejeon, Goyang-si, Gwangju, Gwangmyeong, Incheon, Jeju City, Jeonju, Jinju, Sejong, Seongnam-si, Seoul, Suwon, Uijeongbu-si, Wŏnju, Yangsan, Yŏngin
Age
18 years and over
People
2,040
Run by
Eisai Korea Inc.
See details and how to joinNCT06246123
Phase 2Taking people
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Where
Haeundae, Wŏnju
Age
18 years to 75 years
People
192 worldwide
Run by
Takeda
See details and how to joinNCT06764615 · EU 2024-518914-18-00
Phase 3Taking people
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Where
Daegu, Incheon, Seoul
Age
2 years to 17 years
People
240 worldwide
Run by
Takeda
See details and how to joinNCT05442567 · EU 2023-509046-36-00
No phaseTaking people
Predictors of Prognosis in IBD Patients
Where
Seongnam-si
Age
18 years and over
People
100
Run by
Seoul National University Bundang Hospital
See details and how to joinNCT05653011
No phaseTaking people
A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Where
Goyang-si
Age
18 years and over
People
600
Run by
Takeda
See details and how to joinNCT05428345
No phaseEnrolling by invitation
Research for the Precision Medicine in the Treatment of Inflammatory Bowel Disease
Where
Seoul
Age
10 years and over
People
2,000
Run by
Seoul National University Hospital
See details and how to joinNCT07166588
Phase 2/3Enrolling by invitation
Long-term Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Where
Seoul
Age
10 years to 80 years
People
30
Run by
Seoul National University Hospital
See details and how to joinNCT07154784
No phaseTaking people
SNU IBD Cohort Study : Searching for Characterization of High Risk Populations for Developing Inflammatory Bowel Disease
Where
Seoul
Age
10 years and over
People
500
Run by
Seoul National University Hospital
See details and how to joinNCT07011979
No phaseTaking people
A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea
Where
Seoul
Age
19 years and over
People
3,000
Run by
Bristol-Myers Squibb
See details and how to joinNCT06073873
No phaseTaking people
Gut Microbiome in Inflammatory Bowel Disease
Where
Seoul
People
1,500
Run by
Kyunghee University Medical Center
See details and how to joinNCT03589183
No phaseTaking people
Prediction Model for Response to Biologics and Small Molecular Agent for UC
Where
Seoul
Age
18 years to 79 years
People
300
Run by
Asan Medical Center
See details and how to joinNCT05186623
No phaseTaking people
Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.
Where
Seoul
People
2,000
Run by
Asan Medical Center
See details and how to joinNCT01731665